';
Resolution of gastrointestinal disorders through the use of FORTEBAL® postbiotic in small animals.
Fortebal resultados probados

INTRODUCTION

Symptoms of gastrointestinal disorders are one of the most frequent reasons for consultation in small animal veterinary centers. Although there are different approaches to gastrointestinal disease depending on the severity and etiology of the disease, the use of postbiotics is a novel tool that aids in the treatment of gastrointestinal problems. Postbiotics are made with beneficial bacteria that have antimicrobial, immunomodulatory and microbiota modulating capacity.

In this study, a postbiotic nutritional supplement was developed with two registered strains of lactic acid bacteria. The final product obtained, registered and marketed as
FORTEBAL
®
contains a high concentration of inactivated microbial cells (>108 CFU/mL) in addition to its antimicrobial and immunomodulatory molecules.

 

METHOD

The study was carried out in 6 veterinary centers in the autonomous community of Extremadura in the period from December 2022 to April 2023. The veterinarians of the selected centers were previously trained in the following topics
FORTEBAL
®
, its usefulness and the criteria for inclusion and exclusion of patients. Briefly, the inclusion criterion was considered to be the presence of digestive symptoms with the presence of acute or chronic diarrhea in dogs and cats attending internal medicine, especially of unknown etiology. The presence of vomiting without alterations in stool, toxi-infections or chemical intoxications confirmed by complementary tests and the ingestion of foreign bodies requiring surgery were considered as exclusion criteria.

The administration pattern recommended to the veterinarians of the centers included in the study was 3 doses of 1 mL per 5 kg of weight orally separated at intervals of between 8 and 12 hours. The administration of extra doses was left to the veterinarian’s discretion.

 

RESULTS

The most remarkable clinical result is a reduction of acute diarrhea of food or unknown etiology in dogs with good general health in 90.9% of clinical cases diagnosed by external veterinarians (Table 2). The resolution time for acute diarrhea was between 1 and 5 days. As food etiology, suspected food intolerance, dietary changes or ingestion of spoiled food or foreign bodies that did not require surgery were considered. Stool characteristics and defecation pattern were not included in the objective assessment of symptomatology because they were not observable signs by the veterinarian at the time of consultation.

As for diarrhea of chronic evolution that presented to the internal medicine office due to clinical worsening, a favorable resolution was obtained in 66.7% of the cases. Cases of animals with previous pathologies and chronic, recurrent or complicated gastrointestinal disorders associated with a wide range of etiologies such as paralytic ileus, protein-losing enteropathy and other diseases such as diabetes were considered.

 

CONCLUSIONS

The results of this study confirm the utility of
FORTEBAL
®
to assist conventional treatments of gastrointestinal disorders to achieve a faster and more effective resolution. The novel usefulness of this compound lies in the fact that they have been specifically designed for this purpose based on intensive research work and that they are used in specific clinical cases and in appropriate doses. This experimental design favors the direct application of the research study to clinical practice.

 

BIBLIOGRAPHY .

  1. Allenspach, K., & Gaschen, F. (2003). Chronic intestinal diseases in the dog: A review. Swiss Archive of Landscape Science, 145(5), 209-219.
  2. Washabau, R. J., & Day, M. J. (2012). Canine and feline gastroenterology. Elsevier Health Sciences.
  3. Webb, C., & Twedt, D. C. (2003). Canine gastritis. Veterinary Clinics: Small Animal Practice, 33(5), 969-985.
  4. Tolbert, K., & Gould, E. (2020). Gastritis and gastric ulceration in dogs and cats. Clinical small animal internal medicine, 547-555.
  5. German, A., Halladay, L., & Noble, P. (2010). First-choice therapy for dogs presenting with diarrhoea in clinical practice. Veterinary record, 167(21), 810-814.
  6. Karczewski, J., Poniedziałek, B., Adamski, Z., & Rzymski, P. (2014). The effects of the microbiota on the host immune system. Autoimmunity, 47(8), 494-504.
  7. Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018). Gut microbiota functions: Metabolism of nutrients and other food components. European journal of nutrition, 57(1), 1-24.
  8. Salminen, S., Collado, M. C., Endo, A., Hill, C., Lebeer, S., Quigley, E. M., Sanders, M. E., Shamir, R., Swann, J. R., & Szajewska, H. (2021). The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology, 18(9), 649-667.
  9. Aguilar-Toalá, J., Garcia-Varela, R., Garcia, H., Mata-Haro, V., González-Córdova, A., Vallejo-Cordoba, B., & Hernández-Mendoza, A. (2018). Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology, 75, 105-114.
  10. Bravo, M. (2021). Characterization of lactic acid bacteria with antimicrobial and immunomodulatory properties and their applied research in animal health. University of Extremadura.
  11. Bravo, M., Combes, T., Martinez, F. O., Risco, D., Gonçalves, P., Garcia-Jimenez, W. L., Cerrato, R., Fernandez-Llario, P., & Gutierrez-Merino, J. (2022). Wildlife Symbiotic Bacteria Are Indicators of the Health Status of the Host and Its Ecosystem. Applied and environmental microbiology, 88(1), e01385-21.
  12. Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., & Cani, P. D. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature reviews Gastroenterology & hepatology, 14(8), 491-502.
  13. Xu, H., Huang, W., Hou, Q., Kwok, L.-Y., Laga, W., Wang, Y., Ma, H., Sun, Z., & Zhang, H. (2019). Oral administration of compound probiotics improved canine feed intake, weight gain, immunity and intestinal microbiota. Frontiers in Immunology, 666.
  14. Rose, L., Rose, J., Gosling, S., & Holmes, M. (2017). Efficacy of a probiotic-prebiotic supplement on incidence of diarrhea in a dog shelter: A randomized, double-blind, placebo-controlled trial. Journal of Veterinary Internal Medicine, 31(2), 377-382.
  15. Jensen, A. P., & Bjørnvad, C. R. (2019). Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review. Journal of veterinary internal medicine, 33(5), 1849-1864.
  16. FAO, O. (2001). Report of the FAO expert consultation. WHO on evaluation of the health and nutritional properties of probiotics in foods, including milk powder with live lactic acid bacteria..

 

– – –

This study has been carried out by INGULADOS in collaboration with several veterinary centers in Extremadura.

Comments
Share
admin